Key facts
- This page summarizes Jeffrey A. Meckler's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 11 Apr 2025, 16:15.
Jeffrey A. Meckler - 10 Apr 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- INDP
- Reported as of
- 10 Apr 2025
- Net transaction value
- -$504
- SEC form
- 4
- Accepted by SEC
- 11 Apr 2025, 16:15:21 UTC
- Prior SEC filing
- 26 Nov 2024
- Next SEC filing
- 16 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey Meckler
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey A. Meckler filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 11 Apr 2025.
Change
- Previous filing in this sequence was filed on 26 Nov 2024.
- Current net transaction value: -$504.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INDP
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $176
- Shares
- -4,750
- Change %
- -100%
- Price
- $0.0370
- Shares after
- 0
- Date
- 10 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,750
- Exercise price
- $536.00
- Footnotes
- F1
INDP
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $139
- Shares
- -3,750
- Change %
- -100%
- Price
- $0.0370
- Shares after
- 0
- Date
- 10 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,750
- Exercise price
- $24.60
- Footnotes
- F1
INDP
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $30.08
- Shares
- -813
- Change %
- -100%
- Price
- $0.0370
- Shares after
- 0
- Date
- 10 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 813
- Exercise price
- $425.60
- Footnotes
- F1
INDP
transaction
Derivative
sStock Option (right to buy)
Disposed to Issuer
- Transaction value
- $55.5
- Shares
- -1,500
- Change %
- -100%
- Price
- $0.0370
- Shares after
- 0
- Date
- 10 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,500
- Exercise price
- $425.60
- Footnotes
- F1
INDP
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $57.83
- Shares
- -1,563
- Change %
- -100%
- Price
- $0.0370
- Shares after
- 0
- Date
- 10 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,563
- Exercise price
- $611.20
- Footnotes
- F1
INDP
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $46.25
- Shares
- -1,250
- Change %
- -100%
- Price
- $0.0370
- Shares after
- 0
- Date
- 10 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $355.20
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.